Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). Food and Drug Administration, U.S. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date.

DEA 97

DEA Blood Pressure Safety Policy 97

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? May affect blood pressure, heart rate, intraocular pressure. The second argument is based on a DEA interim final rule on the topic of synthetic THC. Table of Contents. Executive Summary. What We Discovered.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Meaning that unlike regulated products such as foods, beverages and pharmaceuticals, you can not trust the labeling of D-8 products.

THC 98

THC Research and Development Cannabinoids CBD 98